5-FU, Leucovorin, Oxaliplatin and Docetaxel (FLOT) Versus Epirubicin, Cisplatin and 5-FU (ECF) in Patients With Locally Advanced, Resectable Gastric Cancer
Clinical trial NCT01216644 · COMPLETED
Trial details
- NCT number
- NCT01216644
- Sponsor
- Krankenhaus Nordwest
- Status
- COMPLETED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2010-08-01
- Primary completion
- 2017-03-01
- Enrollment
- 716
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.